Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

NCT03433274 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT03433274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03433274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 15, 2018
Completion date
June 30, 2028
Enrollment
103 (actual)
Sites
78

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, degenerative mitral valve disease, functional mitral regurgitation, heart valve diseases, mitral insufficiency, mitral regurgitation, mitral valve insufficiency, valve disease, heart